You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Oral administration of NPC43 counters hyperglycemia and activates insulin receptor in streptozotocin-induced type 1 diabetic mice

Article metrics

Article menu

Download PDFPDF

XML
Emerging technologies, pharmacology and therapeutics
Oral administration of NPC43 counters hyperglycemia and activates insulin receptor in streptozotocin-induced type 1 diabetic mice

 

Online download statistics by month:

Online download statistics by month: September 2020 to March 2024

AbstractFullPdf
Sep 202010510415
Oct 202021521469
Nov 2020525012
Dec 2020656515
Jan 202147448
Feb 202145433
Mar 202141407
Apr 202125255
May 2021262613
Jun 202135375
Jul 2021292913
Aug 2021202012
Sep 202130303
Oct 2021323148
Nov 2021636135
Dec 2021514517
Jan 202225257
Feb 202224239
Mar 2022252514
Apr 2022262610
May 2022222118
Jun 202216136
Jul 202228329
Aug 202221195
Sep 2022292924
Oct 202223217
Nov 2022212018
Dec 202230289
Jan 202325236
Feb 202341438
Mar 2023363417
Apr 2023222118
May 202317156
Jul 202319198
Aug 202324229
Sep 202315157
Oct 202334355
Nov 202328287
Dec 202339389
Jan 202426288
Feb 2024222214
Mar 20241919180
Total15381508718